182 related articles for article (PubMed ID: 31035067)
1. Bioengineered analog of stromal cell-derived factor 1α preserves the biaxial mechanical properties of native myocardium after infarction.
Wang H; Wisneski A; Paulsen MJ; Imbrie-Moore A; Wang Z; Xuan Y; Hernandez HL; Lucian HJ; Eskandari A; Thakore AD; Farry JM; Hironaka CE; von Bornstaedt D; Steele AN; Stapleton LM; Williams KM; Wu MA; MacArthur JW; Woo YJ
J Mech Behav Biomed Mater; 2019 Aug; 96():165-171. PubMed ID: 31035067
[TBL] [Abstract][Full Text] [Related]
2. Mathematically engineered stromal cell-derived factor-1α stem cell cytokine analog enhances mechanical properties of infarcted myocardium.
MacArthur JW; Trubelja A; Shudo Y; Hsiao P; Fairman AS; Yang E; Hiesinger W; Sarver JJ; Atluri P; Woo YJ
J Thorac Cardiovasc Surg; 2013 Jan; 145(1):278-84. PubMed ID: 23244259
[TBL] [Abstract][Full Text] [Related]
3. Natural cardiac regeneration conserves native biaxial left ventricular biomechanics after myocardial infarction in neonatal rats.
Wang H; Wisneski A; Imbrie-Moore AM; Paulsen MJ; Wang Z; Xuan Y; Lopez Hernandez H; Hironaka CE; Lucian HJ; Shin HS; Anilkumar S; Thakore AD; Farry JM; Eskandari A; Williams KM; Grady F; Wu MA; Jung J; Stapleton LM; Steele AN; Zhu Y; Woo YJ
J Mech Behav Biomed Mater; 2022 Feb; 126():105074. PubMed ID: 35030471
[TBL] [Abstract][Full Text] [Related]
4. Preclinical evaluation of the engineered stem cell chemokine stromal cell-derived factor 1α analog in a translational ovine myocardial infarction model.
Macarthur JW; Cohen JE; McGarvey JR; Shudo Y; Patel JB; Trubelja A; Fairman AS; Edwards BB; Hung G; Hiesinger W; Goldstone AB; Atluri P; Wilensky RL; Pilla JJ; Gorman JH; Gorman RC; Woo YJ
Circ Res; 2014 Feb; 114(4):650-9. PubMed ID: 24366171
[TBL] [Abstract][Full Text] [Related]
5. Computational protein design to reengineer stromal cell-derived factor-1α generates an effective and translatable angiogenic polypeptide analog.
Hiesinger W; Perez-Aguilar JM; Atluri P; Marotta NA; Frederick JR; Fitzpatrick JR; McCormick RC; Muenzer JR; Yang EC; Levit RD; Yuan LJ; Macarthur JW; Saven JG; Woo YJ
Circulation; 2011 Sep; 124(11 Suppl):S18-26. PubMed ID: 21911811
[TBL] [Abstract][Full Text] [Related]
6. Spliced stromal cell-derived factor-1α analog stimulates endothelial progenitor cell migration and improves cardiac function in a dose-dependent manner after myocardial infarction.
Hiesinger W; Frederick JR; Atluri P; McCormick RC; Marotta N; Muenzer JR; Woo YJ
J Thorac Cardiovasc Surg; 2010 Nov; 140(5):1174-80. PubMed ID: 20951261
[TBL] [Abstract][Full Text] [Related]
7. Bioengineered stromal cell-derived factor-1α analogue delivered as an angiogenic therapy significantly restores viscoelastic material properties of infarcted cardiac muscle.
Trubelja A; MacArthur JW; Sarver JJ; Cohen JE; Hung G; Shudo Y; Fairman AS; Patel J; Edwards BB; Damrauer SM; Hiesinger W; Atluri P; Woo YJ
J Biomech Eng; 2014 Aug; 136(8):0845011-5. PubMed ID: 24860865
[TBL] [Abstract][Full Text] [Related]
8. Myocardial tissue elastic properties determined by atomic force microscopy after stromal cell-derived factor 1α angiogenic therapy for acute myocardial infarction in a murine model.
Hiesinger W; Brukman MJ; McCormick RC; Fitzpatrick JR; Frederick JR; Yang EC; Muenzer JR; Marotta NA; Berry MF; Atluri P; Woo YJ
J Thorac Cardiovasc Surg; 2012 Apr; 143(4):962-6. PubMed ID: 22264415
[TBL] [Abstract][Full Text] [Related]
9. Sustained release of engineered stromal cell-derived factor 1-α from injectable hydrogels effectively recruits endothelial progenitor cells and preserves ventricular function after myocardial infarction.
MacArthur JW; Purcell BP; Shudo Y; Cohen JE; Fairman A; Trubelja A; Patel J; Hsiao P; Yang E; Lloyd K; Hiesinger W; Atluri P; Burdick JA; Woo YJ
Circulation; 2013 Sep; 128(11 Suppl 1):S79-86. PubMed ID: 24030424
[TBL] [Abstract][Full Text] [Related]
10. Multiaxial Lenticular Stress-Strain Relationship of Native Myocardium is Preserved by Infarct-Induced Natural Heart Regeneration in Neonatal Mice.
Wang H; Bennett-Kennett R; Paulsen MJ; Hironaka CE; Thakore AD; Farry JM; Eskandari A; Lucian HJ; Shin HS; Wu MA; Imbrie-Moore AM; Steele AN; Stapleton LM; Zhu Y; Dauskardt RH; Woo YJ
Sci Rep; 2020 Apr; 10(1):7319. PubMed ID: 32355240
[TBL] [Abstract][Full Text] [Related]
11. Intramyocardial injection of heart tissue-derived extracellular matrix improves postinfarction cardiac function in rats.
Dai W; Gerczuk P; Zhang Y; Smith L; Kopyov O; Kay GL; Jyrala AJ; Kloner RA
J Cardiovasc Pharmacol Ther; 2013 May; 18(3):270-9. PubMed ID: 23345062
[TBL] [Abstract][Full Text] [Related]
12. CineCT platform for in vivo and ex vivo measurement of 3D high resolution Lagrangian strains in the left ventricle following myocardial infarction and intramyocardial delivery of theranostic hydrogel.
Midgett DE; Thorn SL; Ahn SS; Uman S; Avendano R; Melvinsdottir I; Lysyy T; Kim JS; Duncan JS; Humphrey JD; Papademetris X; Burdick JA; Sinusas AJ
J Mol Cell Cardiol; 2022 May; 166():74-90. PubMed ID: 35227737
[TBL] [Abstract][Full Text] [Related]
13. Modification of infarct material properties limits adverse ventricular remodeling.
Morita M; Eckert CE; Matsuzaki K; Noma M; Ryan LP; Burdick JA; Jackson BM; Gorman JH; Sacks MS; Gorman RC
Ann Thorac Surg; 2011 Aug; 92(2):617-24. PubMed ID: 21801916
[TBL] [Abstract][Full Text] [Related]
14. Sustained myocardial production of stromal cell-derived factor-1α was associated with left ventricular adverse remodeling in patients with myocardial infarction.
Uematsu M; Yoshizaki T; Shimizu T; Obata JE; Nakamura T; Fujioka D; Watanabe K; Watanabe Y; Kugiyama K
Am J Physiol Heart Circ Physiol; 2015 Nov; 309(10):H1764-71. PubMed ID: 26408542
[TBL] [Abstract][Full Text] [Related]
15. Chemokine stromal cell-derived factor 1/CXCL12 increases homing of mesenchymal stem cells to injured myocardium and neovascularization following myocardial infarction.
Zhuang Y; Chen X; Xu M; Zhang LY; Xiang F
Chin Med J (Engl); 2009 Jan; 122(2):183-7. PubMed ID: 19187644
[TBL] [Abstract][Full Text] [Related]
16. Biodegradable elastic patch plasty ameliorates left ventricular adverse remodeling after ischemia-reperfusion injury: a preclinical study of a porous polyurethane material in a porcine model.
Hashizume R; Fujimoto KL; Hong Y; Guan J; Toma C; Tobita K; Wagner WR
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):391-9.e1. PubMed ID: 23219497
[TBL] [Abstract][Full Text] [Related]
17. Stromal cell-derived factor-1alpha activation of tissue-engineered endothelial progenitor cell matrix enhances ventricular function after myocardial infarction by inducing neovasculogenesis.
Frederick JR; Fitzpatrick JR; McCormick RC; Harris DA; Kim AY; Muenzer JR; Marotta N; Smith MJ; Cohen JE; Hiesinger W; Atluri P; Woo YJ
Circulation; 2010 Sep; 122(11 Suppl):S107-17. PubMed ID: 20837901
[TBL] [Abstract][Full Text] [Related]
18. The effect of bioengineered acellular collagen patch on cardiac remodeling and ventricular function post myocardial infarction.
Serpooshan V; Zhao M; Metzler SA; Wei K; Shah PB; Wang A; Mahmoudi M; Malkovskiy AV; Rajadas J; Butte MJ; Bernstein D; Ruiz-Lozano P
Biomaterials; 2013 Dec; 34(36):9048-55. PubMed ID: 23992980
[TBL] [Abstract][Full Text] [Related]
19. Chitosan hydrogels significantly limit left ventricular infarction and remodeling and preserve myocardial contractility.
Henning RJ; Khan A; Jimenez E
J Surg Res; 2016 Apr; 201(2):490-7. PubMed ID: 27020836
[TBL] [Abstract][Full Text] [Related]
20. Biomechanical properties of acellular scar ECM during the acute to chronic stages of myocardial infarction.
Brazile BL; Butler JR; Patnaik SS; Claude A; Prabhu R; Williams LN; Perez KL; Nguyen KT; Zhang G; Bajona P; Peltz M; Yang Y; Hong Y; Liao J
J Mech Behav Biomed Mater; 2021 Apr; 116():104342. PubMed ID: 33516128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
